$766 Million is the total value of Foyston, Gordon, & Payne Inc's 85 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TEVA | New | Teva Pharmaceutical - ADR | $29,490,000 | – | 780,584 | +100.0% | 3.85% | – |
| BG | New | Bunge Ltd. | $28,213,000 | – | 371,670 | +100.0% | 3.68% | – |
| CHKP | New | Check Point Software Technologies Ltd. | $21,690,000 | – | 383,488 | +100.0% | 2.83% | – |
| F113PS | New | Covidien PLC | $17,410,000 | – | 285,693 | +100.0% | 2.27% | – |
| VIV | New | Telefonica Brasilsa - ADR | $9,143,000 | – | 407,462 | +100.0% | 1.19% | – |
| PTR | New | Petrochina Co. Ltd. - ADR | $5,697,000 | – | 51,818 | +100.0% | 0.74% | – |
| SNY | New | Sanofi - ADR | $4,597,000 | – | 90,797 | +100.0% | 0.60% | – |
| SEM | New | Select Medical Holdings Corp. | $3,988,000 | – | 494,200 | +100.0% | 0.52% | – |
| KT | New | KT Corp. - ADR | $3,907,000 | – | 232,996 | +100.0% | 0.51% | – |
| PUK | New | Prudential PLC - ADR | $3,581,000 | – | 95,936 | +100.0% | 0.47% | – |
| UL | New | Unilever PLC - ADR | $3,568,000 | – | 92,482 | +100.0% | 0.47% | – |
| ABB | New | ABB Ltd. ADR | $3,504,000 | – | 148,526 | +100.0% | 0.46% | – |
| RDSA | New | Royal Dutch Shell PLC ADR A | $3,466,000 | – | 52,774 | +100.0% | 0.45% | – |
| BBL | New | BHP Billiton PLC-ADR | $3,378,000 | – | 57,386 | +100.0% | 0.44% | – |
| SNN | New | Smith & Nephew PLC - ADR | $3,165,000 | – | 50,698 | +100.0% | 0.41% | – |
| SIEGY | New | Siemens AG-ADR | $2,935,000 | – | 24,356 | +100.0% | 0.38% | – |
| SHG | New | Shinhan Financial Group - ADR | $2,541,000 | – | 62,737 | +100.0% | 0.33% | – |
| TM | New | Toyota Motor Corp. - ADR | $2,535,000 | – | 19,800 | +100.0% | 0.33% | – |
| IBN | New | ICICI Bank Ltd. - ADR | $2,499,000 | – | 82,000 | +100.0% | 0.33% | – |
| SSL | New | Sasol Ltd. - ADR | $1,790,000 | – | 37,449 | +100.0% | 0.23% | – |
| CHL | New | China Mobile HK Ltd. - ADR | $1,640,000 | – | 29,063 | +100.0% | 0.21% | – |
| SBS | New | CIA Saneamento Basico De - ADR | $1,070,000 | – | 107,442 | +100.0% | 0.14% | – |
| NVS | New | Novartis AG - ADR | $661,000 | – | 8,619 | +100.0% | 0.09% | – |
| PFE | New | Pfizer Inc. | $201,000 | – | 6,993 | +100.0% | 0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Frank Russell Company #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2013-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp. | 42 | Q3 2023 | 10.2% |
| Johnson & Johnson | 42 | Q3 2023 | 9.3% |
| Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
| Coca Cola Co. | 42 | Q3 2023 | 1.7% |
| Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
| Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
| Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
| AbbVie Inc. | 42 | Q3 2023 | 0.5% |
| Abbott Laboratories | 42 | Q3 2023 | 0.4% |
| Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
| Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
| TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
| CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.